Related Experiment Video
Updated: Jul 17, 2026

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
Published on: May 3, 2018
Cell-specific responses to loss of cyclin-dependent kinases
1Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute-Frederick, Frederick, MD 21702-1201, USA.
Abstract:
Inactivation of cyclin-dependent kinases (Cdks) and/or cyclins in mice has changed our view of cell cycle regulation. In general, cells are far more resistant to the loss of Cdks than originally anticipated, suggesting widespread compensation among the Cdks. Early embryonic cells are, so far, not sensitive to the lack of multiple Cdks or cyclins. In contrast, differentiated cells are more dependent on Cdk/cyclin complexes and the functional redundancy is more limited. Our challenge is to better understand these cell-type specific differences in cell cycle regulation that can be used to design efficient cancer therapy. Indeed, tumor cells seem to respond to inhibition of Cdk activities, however, with different outcome depending on the tumor cell type. Tumor cells share some proliferation features with stem cells, but appear more sensitive to loss of Cdk activity, somewhat resembling differentiated cells. We summarize the current knowledge of cell cycle regulation in different cell types and highlight their sensitivity to the lack of Cdk activities.
Insights
Cell cycle regulation shows surprising Cdk/cyclin compensation in most cells, but differentiated and tumor cells are more sensitive to Cdk loss, offering cancer therapy insights.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- Cyclin-dependent kinases (Cdks) and cyclins are crucial regulators of the cell cycle.
- Inactivating Cdks in mice revealed unexpected resistance and compensation mechanisms in various cell types.
Purpose of the Study:
- To elucidate cell-type specific differences in cell cycle regulation.
- To explore the potential of targeting Cdk activity for cancer therapy.
Main Methods:
- Review of existing literature on Cdk/cyclin inactivation studies in mice.
- Comparative analysis of cell cycle regulation across embryonic, differentiated, stem, and tumor cells.
Main Results:
- General cell resistance to Cdk loss suggests significant compensatory pathways.
- Early embryonic cells exhibit low sensitivity to multiple Cdk/cyclin deficiencies.
- Differentiated and tumor cells show greater dependence on Cdk/cyclin complexes and limited functional redundancy.
Conclusions:
- Cell-type specific differences in cell cycle regulation are critical.
- Tumor cells, while sharing proliferative traits with stem cells, are more susceptible to Cdk inhibition, resembling differentiated cells.
- Understanding these sensitivities can guide the development of targeted cancer therapies.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Positive Regulator Molecules
Positive Regulator Molecules
Mitogens and the Cell Cycle
Anaphase Promoting Complex

